Embree Financial Group’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
14,214
+1,553
+12% +$226K 0.21% 73
2026
Q1
$1.83M Buy
12,661
+268
+2% +$40.6K 0.22% 79
2025
Q4
$1.78M Buy
12,393
+296
+2% +$43.6K 0.22% 77
2025
Q3
$1.86M Sell
12,097
-42
-0.3% -$6.56K 0.25% 71
2025
Q2
$1.93M Buy
12,139
+7
+0.1% +$1.14K 0.29% 67
2025
Q1
$2.07M Buy
12,132
+53
+0.4% +$8.88K 0.35% 61
2024
Q4
$2.03M Sell
12,079
-75
-0.6% -$12.8K 0.35% 54
2024
Q3
$2.11M Buy
12,154
+269
+2% +$45.7K 0.37% 52
2024
Q2
$1.96M Sell
11,885
-372
-3% -$60.8K 0.38% 54
2024
Q1
$1.99M Sell
12,257
-284
-2% -$44.5K 0.39% 55
2023
Q4
$1.84M Buy
+12,541
New +$1.86M 0.39% 58

Other funds holding PG

Embree Financial Group's PG Position: Q2 2026 in Review

Embree Financial Group increased its Procter & Gamble (PG) stake by 12% in Q2 2026, buying an estimated $226K and bringing the position to 14,214 shares worth $2.08M. The position accounts for 0.21% of the portfolio, ranked #73.

Embree Financial Group first reported a position in PG in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.11M in Q3 2024. 2,087 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Embree Financial Group held 14,214 shares of Procter & Gamble worth $2.08M as of Q2 2026.
  • Embree Financial Group bought 1,553 Procter & Gamble shares in Q2 2026, an estimated $226K.
  • Procter & Gamble made up 0.21% of Embree Financial Group's portfolio in Q2 2026, its #73 holding.
  • Embree Financial Group first reported a position in Procter & Gamble in Q4 2023 and has held it in 11 quarters since.
  • Embree Financial Group's Procter & Gamble position peaked at $2.11M in Q3 2024.
  • 2,087 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.